Prediagnostic genetic stratification for aggressive prostate cancer—is the puzzle for genetic variants gaining shape?

Population-based screening for prostate cancer (PCa) using prostate-specific antigen (PSA) has shown to reduce the cancer-specific mortality but was associated with a high rate of overdiagnosis (1).